Uroplasty, Inc. (AMEX: UPI), a global medical device company, is focused on developing, manufacturing, and marketing products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. The company offers a wide range of products that meet the demands of healthcare professionals and patients. Their devices help healthcare professionals increase the efficiency of their treatment options while reducing patient risk. For further information, visit the Company’s web site at www.uroplasty.com.
- 17 years ago
QualityStocks
Uroplasty, Inc. (AMEX: UPI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – ONAR Holding Corp. (ONAR) CEO Spotlights AI-Driven Strategy for the Middle Market
ONAR (OTCQB: ONAR) was recently featured on the TechMediaWire Podcast, where CEO Claude Zdanow shared his journey…
-
QualityStocksNewsBreaks – Zacks Research Releases Updated Report as Soligenix Inc. (NASDAQ: SNGX) Eyes Upcoming ‘Key Catalysts’
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July…
-
Safe Pro Group Inc. (NASDAQ: SPAI) to Benefit from $33 Billion US Defense Bill Targeting AI and Drone Innovation
Safe Pro Group offers AI-powered computer vision software for analyzing drone imagery to identify small…